In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus

Rift Valley fever virus (RVFV), a recognized category A priority pathogen, causes large outbreaks of Rift Valley fever with some fatalities in humans in humans and huge economic losses in livestock. As wild-type RVFV must be handled in BSL-3 or BSL-4 laboratories, we constructed a high-titer vesicul...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hum Vaccin Immunother
Asıl Yazarlar: Ma, Jian, Chen, Ruifeng, Huang, Weijin, Nie, Jianhui, Liu, Qiang, Wang, Youchun, Yang, Xiaoming
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2019
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816429/
https://ncbi.nlm.nih.gov/pubmed/31170027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1627820
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller